CASPR2 antibody-associated neurological syndrome after PD-1 inhibitor treatment (tislelizumab) in a patient with lung adenocarcinoma: A case report and literature review.
- DOI
- 10.1016/j.jneuroim.2026.579076
- Published
- 2026 Aug 31
- Container
- Journal of neuroimmunology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jneuroim.2026.579076,
title = {CASPR2 antibody-associated neurological syndrome after PD-1 inhibitor treatment (tislelizumab) in a patient with lung adenocarcinoma: A case report and literature review.},
author = {Zhang L and Tai X and Zhao X and Dang C and Xue L and Da D and Zhang X and Li H},
year = {2026},
journal = {Journal of neuroimmunology},
doi = {10.1016/j.jneuroim.2026.579076},
url = {https://doi.org/10.1016/j.jneuroim.2026.579076}
}RIS
TY - JOUR TI - CASPR2 antibody-associated neurological syndrome after PD-1 inhibitor treatment (tislelizumab) in a patient with lung adenocarcinoma: A case report and literature review. AU - Zhang L AU - Tai X AU - Zhao X AU - Dang C AU - Xue L AU - Da D AU - Zhang X AU - Li H PY - 2026 JO - Journal of neuroimmunology DO - 10.1016/j.jneuroim.2026.579076 UR - https://doi.org/10.1016/j.jneuroim.2026.579076 ER -
APA
L, Z., X, T., X, Z., C, D., L, X., D, D., X, Z., & H, L. (2026). CASPR2 antibody-associated neurological syndrome after PD-1 inhibitor treatment (tislelizumab) in a patient with lung adenocarcinoma: A case report and literature review.. Journal of neuroimmunology. https://doi.org/10.1016/j.jneuroim.2026.579076
Source records
- pubmed · retrieved 2026-09-26T21:23:48.840Z